FH
Fathom Holdings Inc. (FTHM)·Q2 2025 Earnings Summary
Executive Summary
- Revenue accelerated 36.1% year over year to $121.4M, a clear beat versus S&P Global consensus of $117.3M; GAAP diluted EPS was a loss of $0.13, below the SPGI Primary EPS consensus of -$0.03, while Adjusted EBITDA turned slightly positive at $29K . Revenue/EPS estimates from S&P Global: $117.3M and -$0.03; actuals: $121.4M and -$0.096* (SPGI Primary EPS), GAAP diluted EPS: -$0.13 .
- Mix and platform strategy progressed: Brokerage revenue +39.6% to $116.0M; Title revenue +88% to $1.5M; Elevate program onboarded 70 agents and is producing materially higher unit economics, with management highlighting 4x gross profit and 5x Adj. EBITDA per transaction versus standard brokerage .
- Guidance remains withheld for Q3 2025 with management targeting reinstatement in Q4; company intends to remain Adjusted EBITDA positive going forward .
- Strategic catalysts: Arizona market expansion via licensing intelliAgent and Elevate (Fathom Elite), repayment of $3.5M convertible note, and $3.0M cash received from the 2024 insurance divestiture, positioning the balance sheet and platform for cross‑sell growth .
What Went Well and What Went Wrong
What Went Well
- Strong top-line beat and mix shift: Total revenue +36.1% to $121.4M driven primarily by My Home Group acquisition and transactions +25.4%; brokerage revenue +39.6% to $116.0M .
- Elevate program momentum and unit economics: 70 agents onboarded; management: “Elevate agents averaging eight transactions per year…transactions from Elevate generate roughly four times the gross profit and five times the adjusted EBITDA of our standard brokerage transaction” .
- Title growth with June record: Title revenue +88% YoY to $1.5M; June produced record month; early cross‑sell traction across Elevate agents and mortgage/title .
What Went Wrong
- EPS miss and GAAP loss widened YoY: GAAP net loss was $(3.6)M; diluted EPS $(0.13) vs SPGI Primary EPS consensus -$0.03, driven partly by a prior-year gain on sale of the insurance business that favored Q2 2024 comparatives .
- Gross margin compression: Management noted gross profit margin fell to 7.7% from 8.5%, reflecting competitive pricing pressure and higher commission splits to attract/retain agents .
- Ancillary segment profitability mixed: Mortgage revenue declined to $3.3M with segment Adj. EBITDA loss; Verus Title grew revenue ~90% but operated at an Adj. EBITDA loss due to growth investments .
Financial Results
Segment revenue (quarterly):
KPIs:
Estimates vs Actuals (SPGI):
Values retrieved from S&P Global.*
Guidance Changes
Other balance sheet items relevant to outlook:
- Repaid $3.5M convertible note on April 7, 2025 .
- Received $3.0M cash in Q2 related to 2024 insurance divestiture .
Earnings Call Themes & Trends
Management Commentary
- “The second quarter marked a clear step forward…we returned to adjusted EBITDA profitability…this momentum positions us to sustainable growth” — Marco Fregenal (CEO) .
- “Elevate is more than a productivity tool…transactions from Elevate generate roughly four times the gross profit and five times the adjusted EBITDA of our standard brokerage transaction” — Marco Fregenal .
- “Verus Title delivered a record-breaking month in June, and our Elevate concierge program is driving measurable gains in agent productivity and engagement” — FQ2 press release .
- “We believe this [Arizona] model can be replicated with hundreds of independent brokerages nationwide…reducing costs, driving productivity, and unlocking recurring high margin revenue” — Marco Fregenal ; licensing agreement announced Aug. 11 .
- “Gross profit margin decreased to 7.7% from 8.5%, primarily due to competitive pricing pressure, higher commission splits…and increased transaction-related costs” — Daniel Weinmann (VP Finance) .
Q&A Highlights
- Q2 call had no analyst Q&A (operator indicated no questions), so guidance clarifications came via prepared remarks (Adj. EBITDA positive; guidance withheld for Q3, possible reinstatement in Q4) .
- Prior quarter themes (for context): Elevate onboarding cadence and unit economics; ancillary adoption programs (ambassador, pilots) to boost mortgage/title attach; agent recruitment via Max/Share; turnover concentrated in low‑production agents .
Estimates Context
- Q2 revenue beat: Actual $121.423M vs SPGI consensus $117.300M*; ~3.5% beat, likely driving upward revisions to near-term revenue trajectory .
- EPS miss: SPGI Primary EPS actual -$0.096* vs consensus -$0.03*; GAAP diluted EPS: -$0.13. Margin compression and lack of the prior-year gain on sale weighed on EPS .
- EBITDA miss (SPGI): Actual -$916K* vs consensus -$192K*; Company’s Adjusted EBITDA $29K positive, underscoring definitional differences between SPGI EBITDA and company’s non‑GAAP .
Values retrieved from S&P Global.*
Key Takeaways for Investors
- Revenue trajectory improving with sequential acceleration and a Q2 beat; mix anchored by My Home Group and broader transaction growth, supportive of potential estimate upgrades on revenue .
- Profitability inflection is nascent (Adj. EBITDA +$29K); margin headwinds (pricing/commission splits) and ancillary segment losses necessitate caution on EPS/EBITDA modeling near term .
- Elevate and intelliAgent licensing can structurally lift unit economics and open platform monetization; watch onboarding pace (target scaling to 300+ agents in 2025) and Arizona rollout for incremental GP/EBITDA per transaction .
- Title is a bright spot (record June, +88% YoY revenue) with capacity investments in place; expect operating leverage to improve as volumes scale through Elevate attach and agent walkovers .
- Balance sheet flexibility improved (note repaid; cash from divestiture), but operating cash flow negative YTD; monitor working capital needs and mortgage warehouse lines utilization .
- Guidance withheld until Q4; management intent to remain Adj. EBITDA positive is constructive, but lack of quantitative ranges keeps uncertainty high—model conservatively on margin recovery timelines .
- Macro setup is gradually improving (inventory, DOM, price reductions); if rates ease into 2026, Fathom’s agent‑centric low cost model and platform cross‑sell could outgrow the market; positioning ahead of macro turns is key .